BACKGROUND: To avoid performing axillary lymph node dissection (ALND) for non-sentinel lymph node (SLN)-negative patients with-SLN positive axilla, nomograms for predicting the status have been developed in many centers. We created a new nomogram predicting non-SLN metastasis in SLN-positive patients with invasive breast cancer and evaluated 14 existing breast cancer models in our patient group. MATERIALS AND METHODS: Two hundred and thirty seven invasive breast cancer patients with SLN metastases who underwent ALND were included in the study. Based on independent predictive factors for non-SLN metastasis identified by logistic regression analysis, we developed a new nomogram. Receiver operating characteristics (ROC) curves for the models were created and the areas under the curves (AUC) were computed. RESULTS: In a multivariate analysis, tumor size, presence of lymphovascular invasion, extranodal extension of SLN, large size of metastatic SLN, the number of negative SLNs, and multifocality were found to be independent predictive factors for non-SLN metastasis. The AUC was found to be 0.87, and calibration was good for the present Ondokuz Mayis nomogram. Among the 14 validated models, the MSKCC, Stanford, Turkish, MD Anderson, MOU (Masaryk), Ljubljana, and DEU models yielded excellent AUC values of > 0.80. CONCLUSIONS: We present a new model to predict the likelihood of non-SLN metastasis. Each clinic should determine and use the most suitable nomogram or should create their own nomograms for the prediction of non- SLN metastasis.
BACKGROUND: To avoid performing axillary lymph node dissection (ALND) for non-sentinel lymph node (SLN)-negative patients with-SLN positive axilla, nomograms for predicting the status have been developed in many centers. We created a new nomogram predicting non-SLN metastasis in SLN-positive patients with invasive breast cancer and evaluated 14 existing breast cancer models in our patient group. MATERIALS AND METHODS: Two hundred and thirty seven invasive breast cancerpatients with SLN metastases who underwent ALND were included in the study. Based on independent predictive factors for non-SLN metastasis identified by logistic regression analysis, we developed a new nomogram. Receiver operating characteristics (ROC) curves for the models were created and the areas under the curves (AUC) were computed. RESULTS: In a multivariate analysis, tumor size, presence of lymphovascular invasion, extranodal extension of SLN, large size of metastatic SLN, the number of negative SLNs, and multifocality were found to be independent predictive factors for non-SLN metastasis. The AUC was found to be 0.87, and calibration was good for the present Ondokuz Mayis nomogram. Among the 14 validated models, the MSKCC, Stanford, Turkish, MD Anderson, MOU (Masaryk), Ljubljana, and DEU models yielded excellent AUC values of > 0.80. CONCLUSIONS: We present a new model to predict the likelihood of non-SLN metastasis. Each clinic should determine and use the most suitable nomogram or should create their own nomograms for the prediction of non- SLN metastasis.
Authors: Matthew S Katz; Linda McCall; Karla Ballman; Reshma Jagsi; Bruce G Haffty; Armando E Giuliano Journal: Breast Cancer Res Treat Date: 2020-02-10 Impact factor: 4.872
Authors: Franco Di Filippo; Simona Di Filippo; Anna Maria Ferrari; Raffaele Antonetti; Alessandro Battaglia; Francesca Becherini; Laia Bernet; Renzo Boldorini; Catherine Bouteille; Simonetta Buglioni; Paolo Burelli; Rafael Cano; Vincenzo Canzonieri; Pierluigi Chiodera; Alfredo Cirilli; Luigi Coppola; Stefano Drago; Luca Di Tommaso; Privato Fenaroli; Roberto Franchini; Andrea Gianatti; Diana Giannarelli; Carmela Giardina; Florence Godey; Massimo M Grassi; Giuseppe B Grassi; Siobhan Laws; Samuele Massarut; Giuseppe Naccarato; Maria Iole Natalicchio; Sergio Orefice; Fabrizio Palmieri; Tiziana Perin; Manuela Roncella; Massimo G Roncalli; Antonio Rulli; Angelo Sidoni; Corrado Tinterri; Maria C Truglia; Isabella Sperduti Journal: J Exp Clin Cancer Res Date: 2016-12-08
Authors: Bello Inua; Victoria Fung; Nour Al-Shurbasi; Sarah Howells; Olga Hatsiopoulou; Praveen Somarajan; Gregory J Zardin; Norman R Williams; Stan Kohlhardt Journal: Mol Clin Oncol Date: 2021-01-21